Studies on the signal transduction passways through IL-12 receptor
Studies on the signal transduction passways through IL-12 receptor
批准号:
14570285
负责人:
YOSHIMOTO Takayuki
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
我们进行了酵母双杂交筛选,鉴定出小鼠鞘氨醇激酶2(SPHK2)是一个与小鼠IL-12Rβ1细胞质相关的分子。对每个分子的各种突变体的分析表明,SPHK2中的富含Pro结构域的区域可能与IL-12Rβ1结合,而IL-12Rβ1细胞质区域中的羧基末端和框II似乎参与了与SPHK2的结合。野生型SPHK2在T细胞杂交瘤中的瞬时表达增强了IL-12诱导的STAT4介导的转录激活。在Th1细胞克隆中异位表达显性负性SPHK2显著降低了IL-12诱导的干扰素-γ的产生,而野生型SPHK2的异位表达则增强了IL-12诱导的干扰素-DNA的产生。相反,该基因的表达对IL-12诱导的增殖影响最小。用逆转录病毒表达系统在激活的原代T细胞中表达显性阴性的SPHK2时,IL-12诱导的干扰素-γ的产生也有类似的下降。这些结果表明,SPHK2与IL-12Rβ1胞浆区相关,可能在调节IL-12信号转导中发挥作用。我们还研究了由IL-27激活的JAK/STAT信号分子,以及STAT1在IL-27介导的反应中的作用。我们发现IL-27在初始的CD4+T细胞中激活了JAK1、-2、TYK2、STAT1、-2、-3和-5。在STAT1缺陷和野生型初始CD4+T细胞之间也观察到了类似的对IL-27的增殖反应。IL-27不能诱导T-bet和IL-12Rβ-2的表达,IL-27和IL-12协同产生γ的作用也受到抑制。这些结果提示,IL-27能激活初始T细胞JAK1、-2、TYK2、STAT1、-2、-3和-5,STAT1在IL-27诱导的T-bet和IL-12Rβ-2的表达中起着不可缺少的作用,但不能促进增殖。
英文摘要
We performed a yeast two-hybrid screening and identified the mouse sphingosine kinase 2 (SPHK2) as a molecule associating with mouse IL-12Rβ1 cytoplasmic region. Analyses on various mutants of each molecule revealed that the region including proline-rich domain in SPHK2 is likely to be responsible for the binding to IL-12Rβ1, while the regions including the carboxyl terminus and Box II in IL-12Rβ1 cytoplasmic region appear to be involved in the binding to SPHK2. Transient expression of wild-type SPHK2 in T cell hybridoma augmented IL-12-induced STAT4-mediated transcriptional activation. Ectopic expression of dominant-negative SPHK2 in Th1 cell clone significantly reduced IL-12-induced IFN-γ production, while that of wild-type SPHK2 enhanced it. In contrast, the expression minimally affected IL-12-induced proliferation. Similar decrease in IL-12-induced IFN-γ production was observed when dominant-negative SPHK2 was expressed in activated primary T cells by using a retroviral expression system. These results suggest that SPHK2 associates with IL-12Rβ1 cytoplasmic region and is likely to play a role in modulating IL-12 signaling. We also investigated the JAK/STAT signaling molecules activated by IL-27 and the role of STAT1 in IL-27-mediated responses using STAT1-deficient mice. We found that IL-27 activated JAK1, -2 TYK2, STAT1,-2,-3, and -5 in naive CD4+ T cells. Comparable proliferative response to IL-27 was observed between STAT1-deficient and wild-type naive CD4+ T cells. In contrast, IL-27 failed to induce T-bet arid IL-12Rβ2 expression, and synergistic IFN-γ production by IL-27 and IL-12 was also impaired in STAT1-deficient naive CD4+ T cells. These results suggest that IL-27 activates JAK1,-2, TYK2, STAT1, -2,-3, and -5 in naive CD4+ T cells and that STAT1 plays an indispensable role in IL-27-induced T-bet and IL-12Rβ2 expression but not proliferation.
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
M.Shimizu et al.: "Modification of tumor cells with Fas(CD95)antigen gene and Fas ligand(CD95L)gene transfection by electroporation for immunotherapy of cancer."Mol.Biotechnol.. 25. 79-87 (2003)
M.Shimizu 等人:“通过电穿孔用 Fas(CD95) 抗原基因和 Fas 配体 (CD95L) 基因转染对肿瘤细胞进行修饰,用于癌症的免疫治疗。”Mol.Biotechnol.. 25. 79-87 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Hisada: "Potent anti-tumor activity of interleukin-27."Cancer Res.. 64. 1152-1156
M.Hisada:“白细胞介素 27 具有有效的抗肿瘤活性。”癌症研究 64. 1152-1156
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Suzuki: "Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells."Anticancer Res.. 23. 3247-3254 (2003)
H.Suzuki:“逆转录病毒介导的 TRAIL 转导和化疗药物协同诱导肉瘤和骨髓瘤细胞的凋亡细胞死亡。”Anticancer Res.. 23. 3247-3254 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Suzuki et al.: "Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co- operatively induce apoptotic cell death in both sarcoma and myeloma cells."Anticancer Res.. 23. 3247-3254 (2003)
H.Suzuki 等人:“逆转录病毒介导的 TRAIL 转导和化疗药物协同诱导肉瘤和骨髓瘤细胞中的细胞凋亡。”Anticancer Res.. 23. 3247-3254 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
D.Nakayama: "Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice."Obes Res.. 11. 87-94 (2003)
D.Nakayama:“谷氨酸钠治疗的肥胖小鼠胰腺中腺泡和胰岛细胞的周转。”Obes Res.. 11. 87-94 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Study on the regulation of immune responses by a novel IL-6/IL-12 family cytokine
-
批准号:24370058
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2012
-
负责人:YOSHIMOTO Takayuki
-
依托单位:
Immune regulation by the IL-6/IL-12 family cytokines
-
批准号:20370049
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$13.23万
-
财政年份:2008
-
负责人:YOSHIMOTO Takayuki
-
依托单位:
Construction of the Remote Education Network for Exchange of Musical Culture
-
批准号:12680259
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:YOSHIMOTO Takayuki
-
依托单位:
Study on the role of IL-12 in protective immunity against infection
-
批准号:09044265
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.5万
-
财政年份:1997
-
负责人:YOSHIMOTO Takayuki
-
依托单位:
海外基金